- Home
- KRMD vs BIOA Comparison
KRMD vs BIOA Comparison
Compare KRMD & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- BIOA
- Stock Information
- Founded
- KRMD 1980
- BIOA 2015
- Country
- KRMD United States
- BIOA United States
- Employees
- KRMD N/A
- BIOA N/A
- Industry
- KRMD Medical/Dental Instruments
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- BIOA Health Care
- Exchange
- KRMD Nasdaq
- BIOA Nasdaq
- Market Cap
- KRMD 126.9M
- BIOA 144.1M
- IPO Year
- KRMD N/A
- BIOA 2024
- Fundamental
- Price
- KRMD $3.29
- BIOA $4.11
- Analyst Decision
- KRMD Strong Buy
- BIOA Hold
- Analyst Count
- KRMD 4
- BIOA 4
- Target Price
- KRMD $4.63
- BIOA $5.67
- AVG Volume (30 Days)
- KRMD 118.8K
- BIOA 246.5K
- Earning Date
- KRMD 05-07-2025
- BIOA 05-06-2025
- Dividend Yield
- KRMD N/A
- BIOA N/A
- EPS Growth
- KRMD N/A
- BIOA N/A
- EPS
- KRMD N/A
- BIOA N/A
- Revenue
- KRMD $35,083,740.00
- BIOA $1,451,000.00
- Revenue This Year
- KRMD $16.50
- BIOA N/A
- Revenue Next Year
- KRMD $15.47
- BIOA N/A
- P/E Ratio
- KRMD N/A
- BIOA N/A
- Revenue Growth
- KRMD 19.65
- BIOA N/A
- 52 Week Low
- KRMD $1.86
- BIOA $2.88
- 52 Week High
- KRMD $5.05
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- KRMD 71.25
- BIOA N/A
- Support Level
- KRMD $2.51
- BIOA N/A
- Resistance Level
- KRMD $2.86
- BIOA N/A
- Average True Range (ATR)
- KRMD 0.19
- BIOA 0.00
- MACD
- KRMD 0.09
- BIOA 0.00
- Stochastic Oscillator
- KRMD 96.12
- BIOA 0.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.